Observational studyBMC medical imaging2026
Microvascular ultrasonography for quantitative evaluation of nailfold vasculature in systemic sclerosis.
Observational study in BMC medical imaging, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSystemic sclerosis (SSc) is characterized by microvascular dysfunction affecting the digital vasculature. Microvascular ultrasonography (MVUS) is a technique capable of detecting low-velocity flow. This study aimed to evaluate nailfold microvasculature in SSc using the MVUS-derived color pixel percentage (CPP) quantitatively.
methodsSeventy-two participants were included in this cross-sectional observational study. Thirty-seven participants had SSc, 19 participants were healthy controls, and 16 individuals were hypertensive, receiving calcium-channel blockers (CaCBs). Nailfold ultrasonography was performed on all ten digits using a 24-MHz linear transducer and MVUS (ultramicro-angiography®, Mindray Resona R9). CPP was defined as the proportion of colored pixels representing detectable microvascular flow within a predefined, standardized nailfold region of interest, using uniform image acquisition and analysis criteria. Inter-observer reliability was assessed using intraclass correlation coefficients (ICCs). Group differences were examined with one-way ANOVA.
resultsCPP measurements demonstrated excellent reproducibility (ICC 0.986–0.996). CPP values were symmetric across digits of both hands in SSc patients and healthy controls. Across all ten digits, CPP values were significantly lower in SSc patients than in healthy controls and CaCB-treated hypertensive individuals (all p < 0.001). CPP values were consistently highest in the HT with CaCBs group.
conclusionMVUS provides a sensitive and reproducible method for quantifying nailfold microvascular flow. The markedly reduced CPP values observed in SSc patients reflect diffuse microvascular impairment associated with the disease. These findings support further investigation of CPP as a quantitative marker of vascular involvement and as a potential tool for future longitudinal evaluation in systemic sclerosis, which may complement existing clinical and morphological assessments of microvascular disease.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.